One in Four Older U.S. Veterans Report Cardiovascular Disease Diagnosis
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 8, 2025 -- One in four older U.S. veterans report being diagnosed with cardiovascular disease (CVD) in their lifetime, according to a study published online Dec. 18 in PLOS Mental Health.
Cailin G. Arechiga, M.P.H., from the Yale School of Public Health in New Haven, Connecticut, and colleagues characterized the current prevalence of CVD and its association with sociodemographic, military, trauma, and clinical variables. The analysis included data from 3,001 U.S. military veterans (60 years of age and older) participating in the National Health and Resilience in Veterans Study.
The researchers found that 25.5 percent of veterans reported having been diagnosed with CVD. CVD was independently associated with older age, cumulative trauma burden, nicotine use disorder, and diagnoses of hypertension, high cholesterol, and diabetes. There was an independent association seen between CVD and a range of mental and physical health conditions (odds ratios, 1.53 to 2.27 and 1.53 to 3.43, respectively).
"Given the broad range of physical and mental health conditions associated with CVD, these findings highlight the importance of integrated and multimodal prevention and intervention efforts for this population," the authors write. "Further research comprised of more diverse samples that employ longitudinal and mechanistic research designs are needed to examine the prevalence of and bidirectional associations of CVD with demographic, military, and clinical characteristics."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-09 12:00
Read more
- Money, Gun Violence, Hate Crimes: Poll Reveals Top Worries at the End of 2024
- Accelerated Aging Linked to Increased Odds of Preneoplastic Polyps in the Colon
- What Works Best to Help Young Vapers Quit?
- Wintertime Is Prime Time for Head Lice: What Parents Need to Know
- DOJ Alleges CVS Facilitated Unlawful Sales, Violating Federal Opioid Regulations
- FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions